274 Participants Needed

Violence Intervention Programs for Gunshot Wounds

AT
SM
Overseen BySandra McKay, MD
Age: < 65
Sex: Any
Trial Phase: Academic
Sponsor: The University of Texas Health Science Center, Houston
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment Enhanced Case Management, Houston-HVIP treatment?

Research shows that hospital-based violence intervention programs (HVIPs), like the Houston-HVIP treatment, can reduce the chances of people getting hurt again after a violent injury. These programs help by providing intensive support and care, which has been shown to lower the rate of violent reinjury and improve mental health and coping strategies.12345

Is the Enhanced Case Management or Houston-HVIP treatment safe for humans?

The available research on hospital-based violence intervention programs (HVIPs) does not specifically address safety concerns, but these programs are generally designed to support recovery and prevent reinjury, suggesting they are safe for participants.23678

How is the Houston-HVIP treatment different from other treatments for gunshot wounds?

The Houston-HVIP treatment is unique because it focuses on hospital-based violence intervention programs that provide intensive, community-based case management to address not only the physical injuries but also the psychological and social needs of patients, aiming to prevent future violence and improve overall health outcomes.2391011

What is the purpose of this trial?

The purpose of this study is to evaluate the effectiveness of Houston-HVIP in reducing the occurrence of repeat firearm violence among adults receiving care at Memorial Hermann Hospital in Houston,to determine the impact of the community-engaged Houston-HVIP program on violent victimization and mental and behavioral health, to assess the impact of the Houston-HVIP program on reducing racial and ethnic disparities among individuals impacted by firearm violence injury, to determine the impact of the community-engaged Houston-HVIP program on physical and behavioral health during the 12-month follow-up period and to identify the predictors of implementation success, including dosage, reach, fidelity, and acceptability from the perspective of gun violence victims, health care providers, and community violence intervention specialists.

Research Team

SM

Sandra McKay, MD

Principal Investigator

The University of Texas Health Science Center, Houston

AT

Alexander Testa, PhD

Principal Investigator

The University of Texas Health Science Center, Houston

Eligibility Criteria

This trial is for adults treated at Memorial Hermann Hospital in Houston for gunshot wounds from community violence. Participants must speak English or Spanish and give informed consent. It excludes those with self-inflicted, accidental, unintentional, or domestic violence-related gunshot injuries.

Inclusion Criteria

Presented for a gunshot injury stemming from community violence at Memorial Hermann Hospital
Provide informed voluntary consent to participate in the study

Exclusion Criteria

Presenting for unintentional gun violence
Presenting for a firearm injury arising from a self-inflicted gunshot
Presenting for an accidental firearm injury
See 1 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants engage in the Houston-HVIP program to reduce repeat violent events and improve mental and behavioral health

12 months
Monthly assessments

Follow-up

Participants are monitored for changes in post-traumatic stress, aggression, and general health

4 weeks

Treatment Details

Interventions

  • Enhanced Case Management
  • Houston-HVIP treatment
Trial Overview The study tests the effectiveness of the Houston-Hospital Violence Intervention Programs (HVIP) on preventing repeat violent incidents and improving mental health among gun violence victims. It also examines racial disparities in firearm injury outcomes and factors influencing program success.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Houston-HVIP treatment groupExperimental Treatment1 Intervention
Group II: Standard of Care groupActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

The University of Texas Health Science Center, Houston

Lead Sponsor

Trials
974
Recruited
361,000+

National Institute of Nursing Research (NINR)

Collaborator

Trials
623
Recruited
10,400,000+

Findings from Research

The study found a low long-term violent-injury recidivism rate of 4.4% among 328 participants in the Prescription for Hope (RxH) hospital-based violence intervention program over an 8-year period, indicating that the program has lasting positive effects on most participants.
Despite the low recidivism rate, many patients still visited the emergency department for non-violent issues, suggesting that HVIPs could enhance their impact by collaborating with organizations focused on preventing substance abuse, suicide, and unintentional injuries.
Long-term evaluation of a hospital-based violence intervention program using a regional health information exchange.Bell, TM., Gilyan, D., Moore, BA., et al.[2019]
The Prescription for Hope (RxH) program significantly reduced the odds of violent reinjury among participants, with a 65% lower chance of being reinjured after a violent incident, based on a study of 992 patients over a 2-year period.
However, participation in RxH was also associated with increased odds of new convictions for violent crime, suggesting that while the program may help prevent further injuries, it may not address underlying issues related to violent behavior.
Violent injury prevention does not equal to violent crime prevention: an analysis of violence intervention program efficacy using propensity score methods.Holler Mph, E., Ortiz Md, D., Mohanty Md Ms, S., et al.[2022]
Hospital-based violence intervention programs (HVIPs) aim to reduce future injuries by engaging individuals who have experienced violence, and a study involving 79 practitioners identified key outcomes like posttraumatic stress symptoms and emotional regulation that should be prioritized in assessing program effectiveness.
The findings suggest that measuring psychosocial health and well-being, alongside traditional outcomes like repeat violence, is crucial for a comprehensive understanding of recovery and can enhance the relevance of HVIP effectiveness studies.
Generating a Core Set of Outcomes for Hospital-Based Violence Intervention Programs.Monopoli, WJ., Myers, RK., Paskewich, BS., et al.[2021]

References

Long-term evaluation of a hospital-based violence intervention program using a regional health information exchange. [2019]
Implementation of an emerging hospital-based violence intervention program: a multimethod study. [2023]
Violent injury prevention does not equal to violent crime prevention: an analysis of violence intervention program efficacy using propensity score methods. [2022]
Violence Prevention Programs Are Effective When Initiated During the Initial Workup of Patients in an Urban Level I Trauma Center. [2023]
Generating a Core Set of Outcomes for Hospital-Based Violence Intervention Programs. [2021]
Positioning public health surveillance for observational studies and clinical trials: The St. Louis region-wide hospital-based violence intervention program data repository. [2022]
Hospital-Based Violence Intervention Programs to Reduce Firearm Injuries in Children: A Scoping Review. [2023]
Cost-benefit analysis simulation of a hospital-based violence intervention program. [2017]
The psychological sequelae of violent injury in a pediatric intervention. [2018]
10.United Statespubmed.ncbi.nlm.nih.gov
Beyond Recidivism: Hospital-Based Violence Intervention and Early Health and Social Outcomes. [2022]
Hospital-based violence intervention programs targeting adult populations: an Eastern Association for the Surgery of Trauma evidence-based review. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security